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Processing of mitochondrial precursor proteins 
M. ARRETZ. H . SCHNEIDER, U . WIENHUES, and W. NEUPERT 
Institut für Physiologische Chemie der Universität München, Goethestraße 33, 8000 München 2, FRG 
Summary 
The mitochondrial processing enzyme consists of two components, the mitochondrial processing 
peptidase (MPP) and processing enhancing protein (PEP). MPP and PEP act cooperatively in 
proteolytic processing of mitochondrial precursor proteins. Most of the mitochondrial precursors 
possess aminoterminal presequences (also called "targeting sequences" or "signal sequences"), that do 
not display a common motif and that show only limited similarities of the cleavage sites. The 
mitochondrial processing peptidase is a metal-dependent endoprotease, sensitive to sulfhydryl-
modifying reagents and appears to belong to a new class of proteases. MPP and PEP, together with 
the core 1 and core 2 proteins of the respiratory complex III, form a new protein family. 
Introduction 
The majority of mitochondrial proteins is encoded by nuclear genes. These genes are 
transcribed and translated into precursor proteins inost of which possess cleavable amino-
terminal presequences. The latter serve as targeting Signals that are recognized by receptors 
on the mitochondrial surface. Mos t precursors are transported through contact sites of the 
outer and inner membrane into the mitochondrial matrix [1 —3]. D ü r i n g or shortly after 
the translocation process, the presequences are proteolytically removed [4 — 8]. In further 
steps, newly imported proteins are sorted into the mitochondrial subcompartments and 
become assembled into macromolecular complexes. In the case of several intermembrane 
space proteins, a second proteolytic cleavage is performed either in the matrix or in the 
intermembrane space [1—3]. 
In this review we want to focus on the first proteolytic Step by which the matrix targeting 
sequences are removed. This reaction takes place in the matrix compartment of the 
mitochondria. Several different names have been proposed in the literature for the enzyme 
catalyzing this reaction; we call it the mitochondrial processing enzyme. The enzyme has 
been analyzed from different sources such as yeast, N . crassa, rat and bovine liver [4, 9 — 13]. 
General properties are i) it is a soluble component; ii) it is dependent on divalent metal 
ions and is inhibited by metal chelators ( E D T A or o-phenanthroline); and iii) it is not 
sensitive to known inhibitors of serine or carboxyl proteases. 
The mitochondrial processing enzyme was initially purified from N . crassa. Two Poly-
peptides, named M P P (mitochondrial processing peptidase) and P E P (processing enhancing 
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Fig. 1. Working model for the 
import of precursor proteins 
and cleavage of targeting se-
quences by the mitochondrial 
processing peptidase (MPP). 
and the processing enhancing 
protein (PEP). 
R, receptor; OM, outer mem-
brane; IMS, inter membrane 
space; IM, inner membrane; N, 
aminoterminus 
protein) were found to be required for activity [14]. They are structurally related but 
functionally different [15]. 
The enzyme was subsequently purified from yeast and rat liver. In these organisms the 
mitochondrial processing enzyme consists also of two proteins [16, 17]. 
Results and discussion 
C h a r a c t e r i s t i c s o f M P P a n d P E P 
O f the two components involved in processing, M P P bears the catalytic activity. It is a 
protein in the mitochondrial matrix and, in Neurospora, represents 0.03% of total 
mitochondrial protein [14]. M P P is encoded by a nuclear gene. The precursor form contains 
a cleavable presequence that becomes processed by the action of its own mature form 
together with P E P . This reflects a general rule of mitochondrial biogenesis, namely that 
preexisting structures are necessary for the formation of new mitochondria [18]. 
In N . crassa processing activity could be reconstituted from the separated components 
M P P and P E P . M P P is the component, which binds M n 2 + and is thus responsible for the 
metal ion requirement of the processing activity [18]. The sensitivity towards metal chelators, 
such as E D T A (ethylene diamine tetraacetate) or o-phenanthroline, is due to this 
requirement. Neurospora M P P is strongly inhibited by the sulfhydryl-modifying reagents 
N-ethylmaleimide ( N E M ) and iodoacetate. The apparent molecular mass of the mature 
M P P is 57 k D , when estimated on SDS-polyacrylamide, and 59 k D , when calculated from 
the amino acid composition [18]. 
P E P is the component that stimulates the catalytic activity of M P P [14]. P E P function 
does not require metal ions and is insensitive to sulfhydryl modifying reagents. The molecular 
mass of P E P in Neurospora is 52 k D according to SDS-polyacrylamide electrophoresis 
and 49.5 k D according to the amino acid composition [19]. P E P is 15 fold more abundant 
than M P P and represents 0.45% of total mitochondrial protein [14]. Seventy percent of 
the P E P detected in Neurospora mitochondria is attached to the inner face of the inner 
membrane; 30% are present in the matrix fraction. It turned out that in N . crassa the 
amino acid sequence of P E P is identical to that of the core 1 protein (or subunit 1) of the 
cytochrome reductase complex (or complex III) of the mitochondrial respiratory chain. 
A single gene has been found to code for P E P and core 1 protein. Core 1 protein isolated 
from purified complex III stimulates the catalytic activity of M P P with the same efficiency 
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as P E P . Thus, Neurospora P E P is a bifunctional protein involved in both electron transport 
and processing of precursor proteins [19]. 
In Saccharomyces cerevisiae, temperature sensitive mutants were characterized which 
accumulated uncleaved precursor proteins at non-permissive temperature. It turned out 
that the gene affected in one complementation group (mas 1/mif 1; mas = mitochondrial 
assembly; mif = mitochondrial import functions) specifies the equivalent to Neurospora 
P E P [20]. The gene affected in the other mutant (mas 2/mif 2) is that for M P P , the catalytic 
component [14, 21]. Subsequently, the two proteins were purified from yeast and found to 
be necessary and sufficient for proteolytic cleavage of mitochondrial precursors. The yeast 
components have apparent molecular masses of 52 k D ( M P P ) and 48 k D (PEP) . It was 
suggested that they form a complex with a molecular mass of about 100 k D [16]. In contrast 
to the Situation in N . crassa, P E P is not identical to the core 1 protein, but has considerable 
sequence similarity to this protein [19]. 
F r o m the matrix fraction of rat liver mitochondria also two proteins were purified which 
are responsible for processing of precursor proteins. Their apparent molecular masses are 
55 k D and 52 k D [17]. It was shown that the 55 k D protein bears the catalytic activity, and 
sequence analysis proved its equivalence to Neurospora and yeast M P P [22], U p o n gel 
Filtration both proteins eluted together with an estimated molecular mass of 105 k D 
indicating that they form a complex [17]. In contrast to yeast and rat, in Neurospora 
formation of a tight complex between M P P and P E P was not observed. 
In summary, in Neurospora crassa, Saccharomyces cerevisiae and rat two proteins are 
necessary for processing of precursor proteins. In each case the protein with the higher 
molecular mass represents M P P , as judged on the basis of both functional and structural 
characteristics. 
The M P P / P E P / c o r e p r o t e i n f a m i l y 
The two components of the matrix processing enzyme, M P P and P E P , and core 1 and core 2 
protein o f respiratory complex III form a protein family [18]. The M P P proteins of N . crassa 
and yeast show sequence identity of 43% [19]. The rat M P P has 36% identity with both 
Neurospora and yeast M P P [22] (Fig . 2 A ) . A common feature of the M P P s from the 
various species is a box o f 15 amino acids that have a very similar distribution of ncgatively 
charged rcsidues (region 1, F ig . 2 A ) . This region is found also in the P E P protein of 
Neurospora crassa. 
Region 1 may be a putative binding site for the positively charged presequences of 
preproteins. Regions of similarity are distributed among the entire protein with the exception 
of a serine-rich Stretch which is located in the middle of Neurospora M P P and which has 
no counterpart in the other members of the M P P / P E P / c o r e protein family. This Stretch 
has a high flexibility according to Computer prediction and thus may form a hinge between 
an amino-terminal and a carboxyl-terminal domain. A Stretch of 33 identical amino acid 
rcsidues with four glycine residues in series is found within Neurospora and yeast M P P , 
and a very similar Stretch is present in rat M P P (region 2, F ig . 2 A ) . This conserved region 
is found only in the M P P proteins and not in the P E P and core proteins. Therefore, it 
might be a candidate for the active site of the peptidase. 
Furthermore, four cysteine residues are conserved in the M P P s from yeast and 
Neurospora. In rat M P P only two cysteine residues of these four are found, namely those in 
the amino-terminal half (shaded, F ig . 2 A ) . These cysteine residues might be involved in the 
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A. V 
MPP rat . . .AirARPKFGSPAHRRFSSGATYPNIPLSSPLPGVPKPIFATVDGQEKFETK 
MPP N.C. MLNRFRPARLVAQSSRCLPLTRARAGPLPVNNART—LATRAAAVNTKEPTERDN 
MPP S.C. ML-RNGVQRLYSNIARTDNFK-
V T T I i D N G L R V A S Q N K F G Q F C T L G I L I N S G S R Y E A K Y L S G I A H F I £ 
ITTLSNGWVASEDLPDAFSGVG\mDAGSRYENDYWGASHIMD 
LSSIJ\NGLKVATSNTPGHFSALGLYIDAGSRFEGRNIJ<GCTHIIJDRI^ 
TMYAVSADSKGLDTWGLLADWLHPRTLDE EIEMTRMAVQFELED: .NMRPDPEPLLTEMI 
MMYQAATFNKAIPTAVELMAETIRDPKLTDEELEGQIMTAQYEVNE: 
LMY QAS VFNQDVGKMLQLMS ETVRFP KITEC ELQEQKLSAEYE IDE^ fWMKP 
HEAAFRENTVGLHRFCPVE 
WSKA—ELTLPELVHMAAFKDNTLGNPLLCPKE 
—ELVLPELLHTAAYSGETLGSPLICPRE 
NIGKIDREVLHSIJ<N-YYTPDRMVLAGVGVEHEHLVECARKYLLGVQPAWGAPGA 
RIJ5YINRDVIQTYRDAFYRPERLVVAFAGVPHERAVKLAEKYF 
LIPSISKY YLLDYRNKFYTPENTVAAFVGVPHEKALELTEKYL-EDWQSTHPPI 
VWMLTAQ-WHSTRGGSSRWR-ETCQMSALRPPRFQS SHIYG 
* * * * * * * * 
SSSDSSESSGGLLSKLFSPKAKKAITNPFLTRWISTEDLTT^P-AHYT-GGFLTLPSQPPPLNPNLPTF THIQL 
TKKVAQYT-GG ESCI—PPAPVFGNLPELFHIQI 
GFEGLPIDHI 
GARELLLLEI DFIPFA\^NMMMGGGGSFSAGGPGKGMFSRLYLNVLNJ HHWMYNATSYHHSYEDTGLLCIHASADPRQVR 
AFEGIAISDCJDIYAIATLQTLLGGGGSFSAGGPGKGMYSRLYTNVLNC HGWVESCVAFNHSYTDSGLFGIAASCYPGRTL 
DI YAI.ATLQTLLGGGG SF S AGGPG KGMY S RL YT HVLNQ Y YF VENC VAFN HS Y S D S GIFGIS LSCIP 
EMVE11TKEFILM GRTVDLX 
PMLQVMCRELHALTTDHGYSA-
Q AVE VIA-QQMYNTTANKD LR-
ELE~RAKTQLMSMLMMNLESRPVIFEDVGRQ\ LATHSRKLPHELCTLIRNVKPE' 
LC ELEVSRAKNQLRSSLLMNLESRMVELEDLGRQV QV-
I EDEVSRAKNQLKSSLLMNLESKI,VELEDMGRQ\ LM-
-HGRKIPVREMTRRINELTVK 
-HGRKIPVNEMISKIEDLKPD 
DIKRVASKMLRGKPAVAALGDLTDLPTYEHIQAALSSRDGRLPRTYRLFR 
D LRRVAKRWGGMANNAGQGSGAPTWLQE ATVQG- LKTTE LGWDQIQDTIAQWKLGRR 
DISRVAEMIFTGNVNNAGNGKGRATVVMQGDRGSFGDVENVIJCAYGLGNSSSSKNDSPKKKGW 
Fig. 2A 
catalytic activity. A further highly conserved region (region 3, F i g . 2B) is present in all 
members of the protein family. 
PEP/core 1 protein from N . crassa shares 23% and 26% sequence identity with M P P 
from yeast and N . crassa (Fig. 2B) . O n the other hand, N . crassa PEP/core 1 has 5 1 % 
identity to yeast P E P and 32% to yeast core 1 protein. Furthermore, P E P and core 1 from 
yeast are only 24% identical (Fig . 2C) . These sequence similarities are in line with the finding, 
that PEP/core 1 is bifunctional in Neurospora, whereas there are two proteins with separate 
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Fig. 2B. 
functions in yeast [19]. The amino-terminal half of Neurospora PEP/core 1 and of yeast 
P E P have a higher similarity (63%) than those of Neurospora PEP/core 1 and yeast core 1 
(23%). In contrast, the carboxyl-terminus of Neurospora PEP/core 1 is more closely related 
to that one of the yeast core 1 protein than to the carboxyl-terminus of yeast P E P (Fig . 2B) . 
These findings support the hypothesis that the Neurospora PEP/core 1 protein has two 
domains. The amino-terminal domain might be responsible preferentially for the P E P 
function, whereas the carboxyl-terminal domain might bear the core function. The question 
arises as to whether the Situation in Neurospora reflects an exceptional case, or whether, 
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C. 
N. crassa PEP/core1 
S. cerevisiae 
Fig. 2. A. Sequence alignment of rat, Neurospora and yeast MPP. Identical residues are marked by 
asterisks. Cleavage sites of the presequences of rat and Neurospora MPP are marked by arrows. The 
regions of similarity regarding a S t r e t c h rieh in negatively charged amino acids (1) and the two strongly 
conserved regions (2, 3) are indicated by shaded boxes. The conserved cysteine residues are cross-
halched 
B. Sequence alignment of Neurospora crassa (N.) MPP and PEP/core 1 and of yeast (y.) MPP. core 1 
(c. 1) and core 2 (c. 2). Identical residues are shaded and highly conserved regions 1 —3 are indicated 
by overlining. 
C. Sequence identities among the PEP/core 1 Polypeptides of N. crassa and yeast (S. cerevisiae) 
as in yeast, the non-identity of P E P and core 1 is the general Situation. A n answer wil l be 
provided by sequencing the proteins of mammalian processing peptidases and cytochrome 
reduetase complexes. The question remains whether the original function o f this protein 
was that o f a PEP- l ike molecule or was that of a core 1 protein. There are some indications 
that divergence started with the P E P function. Interestingly, the cytochrome bcl complex 
of photosynthetic bacteria and the homologous cytochrome b 6 f complex of chloroplasts 
and eyanobacteria do not have core proteins [23, 24]. Several lines of evidence suggest that 
the role of mitochondrial core 1 and 2 proteins is to stabilize complex III and to facilitate 
assembly of this multicomponent Systems [25], One may speculate that a basic function of 
the core 1/PEP protein is exerted by protein-protein interactions. The role of P E P might 
be to interact with precursor proteins and to present them to M P P in such a conformation 
that the cleavage site becomes accessible. 
S p e c i f i c i t y of t h e m i t o c h o n d r i a l p r o c e s s i n g p e p t i d a s e 
The presequences of imported precursor proteins are characterized by i) a high content of 
positively charged amino acid residues; ii) an almost complete lack of acidic amino acid 
residues; iii) presence of many hydroxylated residues and iv) by the absence of a common 
motif or consensus of the amino acid sequence. 
Mos t precursor proteins have positively charged amino acids in the —2 position (the 
penultimate amino acid of the presequence). Out of 15 precursor proteins (yeast and 
N . crassa) which where proteolytically processed by Neurospora mitochondria, 12 possess 
an A r g , one a Lys , one a Leu and one a V a l residue at this position [2]. Wi th the purified 
processing peptidase of Neurospora crassa 11 precursors were tested. A l l of them contained 
an A r g residue in the —2 position and all o f them were proteolytically processed 
(see table 1). When the arginine residue in the —2 position of a hybrid protein (containing 
an amino-terminal Stretch of the precursor to cytochrome b 2 fused to dihydrofolate reduetase 
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Table 1 
Processing of precursor proteins by the purified processing peptidase. The arrows mark the cleavage 
sites; [ dctermined, ] putative; [] uncleavable by Neurospora enzyme; u, unpublished results. Basic 
(+) and acidic (—) amino acids are indicated 
Neurospora crassa: 
Fi ATPase ß AlaLeuSerArg* Phe 1 AlaSerSerAlaGly [26] 
F 0 AT Päse 9 ValSerLys + Arg + Thr 
Arg + AlaValArg + Ala 
PheAlaLys + Arg + Ser 
! IleGlnThrGlySer [12] 
Rieske Fe/S protein i LeuThrThrSerThr [27] 
Cytochrome cx 1 AlaSerThrGlnSer [28] 
Cytochrome oxidase IV ThrValValArg + Cys 
SerLys + AlaArg + Ala 
1 AsnAlaGlu"ThrLys + [29] 
Cyclophilin 1 PheSerGlnThrSer [30] 
PEP ProPheArg + Arg + Ala 1 Lys + AlaThrProHis [14] 
MPP Asp Asp AlaArg + Gly| Lys + AlaThr Arg + Ala [18] 
Saccharomyces cerevisiae: 
Cytochrome b 2 
ATP 11 protein 
ATP 12 protein 
Bovine: 
Phosphate carrier 
Adrenodoxin (pBAdx-4) 
Human: 
Ornithine transcarbamylase 
AspThrIleArg + Ala j ThrGlySerThrVal 
Lys + LeuProArg+Phe | TyrSerLeuAsnAla 
ProValPheArg + Phe ] TyrSerSerSerPro 
AsnLeuAlaAlaAla 
SerGlyArg + AlaGln 
PheMetValArg+Asn 
-5 -4 - 3 - 2 - 1 
| AlaValGkrGlu-Gln 
l SerSerSerGlu"Asp~ 
i PheArg+CysGlyGln 
+ 1+2+3 +4 +5 
[u] 
[31] 
[31] 
[32] 
[33] 
[6] 
[Ref.] 
[pb2DHFR]) was exchanged against a glycine residue, processing did not occur with 
Neurospora mitochondria, nor with the purified Neurospora enzyme [unpublished results: 
A R R E T Z , M . , U . W I E N H U E S , B . G U I A R D , W . N E U P E R T ] . 
The results suggest that the positively charged amino acid in the —2 position plays an 
important role in the processing of precursor proteins of Neurospora crassa and yeast. In 
addition to the nature of the amino acids, the cleavage site of the presequence and the 
mature part may be important. 
The features determining cleavage sites of precursor proteins of mammalian cells are less 
clear. Only 8 out of 23 mammalian precursor proteins analyzed thus far have an arginine 
residue in the —2 position. In an i n v i t r o System, where the processing was monitored with 
purified processing peptidase of rat, only one out of 7 precursor proteins had a positively 
charged amino acid in the —2 position [8, 17, 22]. This implies that the rat liver enzyme 
has a somewhat different specificity as compared to the fungal enzymes. In this context it 
is not surprising that some precursor proteins from mammalian organisms (adrenodoxin 
and phosphate carrier from bovine) were not processed by the purified Neurospora enzyme 
(see table 1), whereas the purified rat enzyme was observed to process precursors from 
Neurospora and yeast [22]. 
The mitochondrial processing peptidase is an endopeptidase; the enzyme in matrix 
fractions from rat liver mitochondria as well as the purified Neurospora enzyme makes a 
Single cut, and the resulting prepeptide could be recovered [17, unpublished results 
M . A R R E T Z and W . N E U P E R T ] . Despite that there is no common motif in the presequences, 
the enzyme is able to specifically cleave several hundred precursor proteins. We propose 
that the high specificity of cleavage is based on the cooperative action of the two components 
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M P P and P E P . Both may recognize certain structures in the presequence and/or the mature 
part of precursor proteins and thereby contribute to specific recognition of the cleavage 
site. 
M P P i s a member o f a new p r o t e a s e class 
In order to group M P P of Neurospora crassa into one of the four well characterized 
protease classes, i.e. serine proteases, metalloproteases, cysteine proteases and the carboxyl 
proteases, we analyzed the influence of several inhibitors on the catalytic activity of M P P ; 
we also searched for sequence similaritics of M P P to known proteases. 
Phenylmethylsulfonylfluoride ( P M S F ) , an inhibitor o f serine proteases, has no effect on 
M P P . The metal chelators E D T A and o-phenanthroline abolished completely the processing 
of precursors by M P P (see Table 2). This led to the Suggestion that M P P is a metalloprotease 
[4, 14, 16, 17]. However, by sequence comparison of Neurospora M P P with known 
metalloproteases we did not find any similarity [35]. 
M P P of Neurospora and yeast contain four cysteines at identical positions. We addressed 
the question if these cysteines are involved in processing. When Neurospora M P P was 
treated with the sulfhydryl-modifying reagent N-ethylmaleimide ( N E M ) , processing activity 
was strongly reduced. W i t h /?-chloromercuribenzoate, M P P was also completely inhibited. 
These results indicated that at least one thiol group of M P P is necessary for catalytic 
activity. However, specific inhibitors of cysteine proteases, chicken cystatin [36] and E-64 
[37] did not affect the catalytic activity of M P P (see Table 2). Therefore, it is more likely 
that the cysteine(s) are conformational determinants rather than being involved in the 
catalytic event. This is supported by the finding of NEM-insens i t iv i ty of the purified 
peptidase from rat liver mitochondria [22]. 
Attempts to detect sequence similarities to several members o f the known classes of 
proteases were negative [18, 38]. 
Other proteases involved in protein topogenesis such as bacterial leader peptidase, 
eukaryotic signal peptidase o f endoplasmatic reticulum or the thylakoidal peptidase o f 
chloroplasts could also not be grouped into the known protease classes. They show a similar 
unusual specificity as mitochondrial processing peptidase, since they also cleave hundreds 
Table 2 
Effect of inhibitors on the catalytic activity of Neurospora MPP. The processing activity of MPP 
(25 ng, supplemented with 25 ng PEP) without addition of inhibitors was sei to 100%. The assay was 
performed at 25 °C for 30 min with Neurospora as a S u b s t r a t e 
Additions Concentration [mM] Relative activity [%] 
PMSF 1-5 100 
EDTA 2-5 <5 
o-Phenanthroline 5.0 <5 
1,10-Phenanthroline 5.0 <5 
N-ethylmaleimide 10.0 <5 
Iodoacetate 10.0 33 
lodoacetamide 10.0 65 
p-Chloromercuribenzoate 0.01 <5 
Chicken cystatin 0.001-0.5 100 
E-64 0.02-0.5 100 
Pepstatin 0.0001-0.1 100 
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o f different preproteins which have little or no sequence similarity of the prepieces and (at 
lcast with the chloroplast enzyme) limited similarity of the cleavage sites. In summary, the 
mitochondrial processing enzyme appears to belong to a new class of proteases with an 
unknown, yet rather i n t r i g u i n g catalytic mechanism. 
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